<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10012</article-id><article-id pub-id-type="doi">10.7554/eLife.10012</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Registered Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Human Biology and Medicine</subject></subj-group></article-categories><title-group><article-title>Registered report: <italic>Fusobacterium nucleatum</italic> infection is prevalent in human colorectal carcinoma</article-title> </title-group><contrib-group><contrib contrib-type="author" id="author-33484"><name><surname>Repass</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17529"><name><surname>Maherali</surname><given-names>Nimet</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-29160"><name><surname>Owen</surname><given-names>Kate</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="group-author-key">group-author-id1</contrib-id><collab>Reproducibility Project: Cancer Biology</collab><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><label>1</label><institution>ARQ Genetics</institution>, <addr-line><named-content content-type="city">Bastrop</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution>Harvard Stem Cell Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><label>3</label><institution>University of Virginia</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sears</surname><given-names>Cynthia L</given-names></name><role>Reviewing editor</role><aff id="aff4"><institution>Johns Hopkins University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="author non-byline"><contrib-id contrib-id-type="group-author-key">group-author-id1</contrib-id><name><surname>Iorns</surname><given-names>Elizabeth</given-names></name><aff><institution>Science Exchange</institution>, <addr-line><named-content content-type="city">Palo Alto</named-content></addr-line>, <country>United States</country></aff></contrib><contrib contrib-type="author non-byline"><contrib-id contrib-id-type="group-author-key">group-author-id1</contrib-id><name><surname>Gunn</surname><given-names>William</given-names></name><aff><institution>Mendeley</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib><contrib contrib-type="author non-byline"><contrib-id contrib-id-type="group-author-key">group-author-id1</contrib-id><name><surname>Tan</surname><given-names>Fraser</given-names></name><aff><institution>Science Exchange</institution>, <addr-line><named-content content-type="city">Palo Alto</named-content></addr-line>, <country>United States</country></aff></contrib><contrib contrib-type="author non-byline"><contrib-id contrib-id-type="group-author-key">group-author-id1</contrib-id><name><surname>Lomax</surname><given-names>Joelle</given-names></name><aff><institution>Science Exchange</institution>, <addr-line><named-content content-type="city">Palo Alto</named-content></addr-line>, <country>United States</country></aff></contrib><contrib contrib-type="author non-byline"><contrib-id contrib-id-type="group-author-key">group-author-id1</contrib-id><name><surname>Perfito</surname><given-names>Nicole</given-names></name><aff><institution>Science Exchange</institution>, <addr-line><named-content content-type="city">Palo Alto</named-content></addr-line>, <country>United States</country></aff></contrib><contrib contrib-type="author non-byline"><contrib-id contrib-id-type="group-author-key">group-author-id1</contrib-id><name><surname>Errington</surname><given-names>Timothy</given-names></name><aff><institution>Center for Open Science</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>nicole@scienceexchange.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>02</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>e10012</elocation-id><history><date date-type="received"><day>13</day><month>07</month><year>2015</year></date><date date-type="accepted"><day>30</day><month>11</month><year>2015</year></date><fn><p><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellarin</surname><given-names>M</given-names></name><name><surname>Warren</surname><given-names>RL</given-names></name><name><surname>Freeman</surname><given-names>JD</given-names></name><name><surname>Dreolini</surname><given-names>L</given-names></name><name><surname>Krzywinski</surname><given-names>M</given-names></name><name><surname>Strauss</surname><given-names>J</given-names></name><name><surname>Barnes</surname><given-names>R</given-names></name><name><surname>Watson</surname><given-names>P</given-names></name><name><surname>Allen-Vercoe</surname><given-names>E</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name></person-group><day>22</day><month>02</month><year iso-8601-date="2012">2012</year> <article-title>Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma</article-title> .<source>Genome Research</source><volume>22</volume> : <fpage>299</fpage> – <lpage>306</lpage> . doi: <pub-id pub-id-type="doi">10.1101/gr.126516.111</pub-id>.</mixed-citation></p></fn></history><permissions><copyright-statement>© 2016, Repass et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Repass et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-10012-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.10012.001</object-id><p>The <ext-link ext-link-type="uri" xlink:href="https://osf.io/e81xl/wiki/home/">Reproducibility Project: Cancer Biology</ext-link> seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of <ext-link ext-link-type="uri" xlink:href="https://osf.io/e81xl/wiki/studies/">citations and Altmetric scores</ext-link> (<xref ref-type="bibr" rid="bib9">Errington et al., 2014</xref>). This Registered Report describes the proposed replication plan of key experiments from '<italic>Fusobacterium nucleatum</italic> infection is prevalent in human colorectal carcinoma' by Castellarin and colleagues published in <italic>Genome Research</italic> in 2012 (<xref ref-type="bibr" rid="bib5">Castellarin et al., 2012</xref>). The experiment to be replicated is reported in Figure 2. Here, Castellarin and colleagues performed a metagenomic analysis of colorectal carcinoma (CRC) to identify potential associations between inflammatory microorganisms and gastrointestinal cancers. They conducted quantitative real-time PCR on genomic DNA isolated from tumor and matched normal biopsies from a patient cohort and found that the overall abundance of <italic>Fusobacterium</italic> was 415 times greater in CRC versus adjacent normal tissue. These results confirmed earlier studies and provide evidence for a link between tissue-associated bacteria and tumorigenesis. The Reproducibility Project: Cancer Biology is a collaboration between the <ext-link ext-link-type="uri" xlink:href="http://centerforopenscience.org/">Center for Open Science</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.scienceexchange.com/">Science Exchange</ext-link> and the results of the replications will be published in <italic>eLife</italic>.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.10012.001">http://dx.doi.org/10.7554/eLife.10012.001</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>Reproducibility Project: Cancer Biology</kwd><kwd>methodolgy</kwd><kwd><italic>fusobacterium nucleatum</italic></kwd><kwd>colorectal carcinoma</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Laura and John Arnold Foundation</institution></institution-wrap></funding-source><principal-award-recipient><institution>Reproducibility Project: Cancer Biology</institution></principal-award-recipient></award-group><funding-statement>The Reproducibility Project: Cancer Biology is funded by the Laura and John Arnold Foundation, provided to the Center for Open Science in collaboration with Science Exchange. The funder had no role in study design or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The human intestine is populated by an estimated 10<sup>14</sup> microbes comprising over 1000 bacterial phylotypes (<xref ref-type="bibr" rid="bib20">Ley et al., 2006</xref>). The overall composition of the intestinal microbiota is determined by a number of factors, including host genetics, environment, diet and hygiene (<xref ref-type="bibr" rid="bib1">Arrieta et al., 2014</xref>; <xref ref-type="bibr" rid="bib16">Keku et al., 2015</xref>). These bacteria play important roles in host biology by maintaining intestinal homeostasis, barrier function, immunity and metabolic function (<xref ref-type="bibr" rid="bib4">Backhed et al., 2005</xref>; <xref ref-type="bibr" rid="bib15">Jones et al., 2014</xref>). Perturbations or imbalances in the microbiome (microbial dysbiosis) are linked to a number of disease pathologies such as inflammatory bowel disease (<xref ref-type="bibr" rid="bib7">Collins, 2014;</xref> <xref ref-type="bibr" rid="bib14">Hold et al., 2014</xref>), obesity (<xref ref-type="bibr" rid="bib2">Bajzer and Seeley, 2006</xref>; <xref ref-type="bibr" rid="bib3">Brown et al., 2012</xref>), and colorectal cancers (CRCs; <xref ref-type="bibr" rid="bib8">Dulal and Keku, 2014</xref>; <xref ref-type="bibr" rid="bib16">Keku et al., 2015</xref>).</p><p>CRC is a complex disease arising from the sequential accumulation of somatic mutations and epigenetic alterations. Activating mutations in the <italic>K-ras</italic> oncogene, as well as the loss of tumor suppressor genes like <italic>p53</italic> (<italic>TP53</italic>) and adenomatous polyposis coli (<italic>APC</italic>), contribute to the tumorigenic transformation of normal colonic epithelium (<xref ref-type="bibr" rid="bib29">Vogelstein et al., 1988</xref>; <xref ref-type="bibr" rid="bib11">Fearon, 2011;</xref> <xref ref-type="bibr" rid="bib23">Mundade et al., 2014</xref>). In addition to genetic factors, microbial dysbiosis, such as altered bacterial diversity, is strongly associated with the development of CRC (<xref ref-type="bibr" rid="bib16">Keku et al., 2015</xref>). However, despite numerous longitudinal studies comparing intestinal microbial communities over time (<xref ref-type="bibr" rid="bib25">Rodriguez et al., 2015</xref>), and across various cancer stages (<xref ref-type="bibr" rid="bib19">Kubota, 1990;</xref> <xref ref-type="bibr" rid="bib6">Chen et al., 2013;</xref> <xref ref-type="bibr" rid="bib24">Nugent et al., 2014</xref>), there is limited information on the contribution of specific bacteria to CRC development.</p><p>To identify potential associations between inflammatory microorganisms and gastrointestinal cancers, <xref ref-type="bibr" rid="bib5">Castellarin et al. (2012)</xref> first performed RNA sequencing (RNA-seq) on a limited number of tumor and matched normal tissue samples. Initial observations indicated a striking overrepresentation of <italic>Fusobacterium nucleatum</italic> sequences in carcinoma samples compared to controls. To confirm these findings, <xref ref-type="bibr" rid="bib5">Castellarin et al. (2012</xref>) assessed the relative abundance of <italic>Fusobacterium</italic> in a larger cohort of tumor and matched normal biopsy samples. In Figure 2, the authors performed quantitative real-time PCR (qPCR) on genomic DNA (gDNA) isolated from an additional 88 colorectal carcinoma (CRC) specimens and adjacent matched control tissues. <italic>Fusobacterium</italic> abundance was observed to be significantly higher in the tumor samples compared to matching control samples. This key experiment will be replicated in Protocol 1.</p><p>Similar findings confirming the higher relative abundance of <italic>Fusobacterium</italic> in CRC tumor tissues compared to control biopsies have been reported by other investigators (<xref ref-type="bibr" rid="bib18">Kostic et al., 2012</xref>; <xref ref-type="bibr" rid="bib21">McCoy et al., 2013</xref>; <xref ref-type="bibr" rid="bib30">Warren et al., 2013</xref>; <xref ref-type="bibr" rid="bib27">Tahara et al., 2014</xref>). In fact, the study by <xref ref-type="bibr" rid="bib18">Kostic et al. (2012)</xref> is considered a co-discovery of this phenomenon. <xref ref-type="bibr" rid="bib21">McCoy et al. (2013)</xref> successfully validated the association between <italic>Fusobacterium</italic> and CRC in a set of matched CRC tumor and normal human colon tissue samples using both pyrosequencing and qPCR analysis of the <italic>16S</italic> bacterial rRNA gene. Findings by <xref ref-type="bibr" rid="bib22">Mira-Pascual et al. (2015)</xref> further confirm this trend, as this group observed a significantly higher presence of <italic>F. nucleatum</italic> in mucosal samples from the CRC patients compared to the healthy subjects (as opposed to matched tissue biopsies). Recent studies have also reported a higher presence of <italic>Fusobacterium</italic> species in human colonic adenomas (polyps) and in stool samples from adenoma and tumor carcinoma patients compared to healthy subjects (<xref ref-type="bibr" rid="bib18">Kostic et al., 2012</xref>; <xref ref-type="bibr" rid="bib17">2013</xref>; <xref ref-type="bibr" rid="bib21">McCoy et al., 2013</xref>). Furthermore, other studies have expanded these findings to identify potential mechanisms of action of <italic>F. nucleatum</italic> during tumorigenesis (<xref ref-type="bibr" rid="bib26">Rubinstein et al., 2013</xref>; <xref ref-type="bibr" rid="bib13">Gur et al., 2015</xref>). <xref ref-type="bibr" rid="bib26">Rubenstein et al. (2013)</xref> also indirectly confirm a higher abundance of <italic>Fusobacterium</italic> in CRC patients by measuring higher <italic>F. nucleatum</italic> FadA mRNA expression relative to healthy controls.</p></sec><sec id="s2" sec-type="materials|methods"><title>Materials and methods</title><p>Unless otherwise noted, all protocol information was derived from the original paper, references from the original paper, or information obtained directly from the authors. An asterisk (*) indicates data or information provided by the Reproducibility Project: Cancer Biology core team. A hashtag (#) indicates information provided by the replicating lab.</p><sec id="s2-1"><title>Protocol 1: quantitative PCR for amplification of <italic>F. nucleatum</italic> from matched normal and tumor human colon cancer specimens</title><p>This protocol utilizes quantitative PCR to test the relative abundance of <italic>F. nucleatum</italic> DNA in gDNA isolated from matched normal and tumor human colon cancer specimens. It is a replication of Figure 2.</p><sec id="s2-1-1"><title>Sampling</title><list list-type="bullet"><list-item><p>This experiment will include 40 matched samples for a final power of 87.26%.<list list-type="bullet"><list-item><p>See power calculations for details.</p></list-item></list></p></list-item><list-item><p>Each patient sample has two cohorts:<list list-type="bullet"><list-item><p>Cohort 1: Colon tumor sample (<italic>n</italic> = 40)</p></list-item><list-item><p>Cohort 2: Matched normal tissue within the same individual (<italic>n</italic> = 40)</p></list-item><list-item><p>Cohort 3: Age/ethnicity-matched normal tissue from additional control individuals (<italic>n</italic> = 40)</p></list-item></list></p></list-item><list-item><p>Tissue is collected during surgery (either partial colectomy, ileocolectomy, colorectal resection, or proctocolectomy) from tumor tissue, adjacent normal tissue, or from normal controls. Samples are frozen on liquid nitrogen within 30 min after extractions. Diagnosis is confirmed by a pathologist using histological sections from each sample.</p></list-item><list-item><p>Quantitative PCR will be performed for each sample two independent times in technical triplicate for the following:<list list-type="bullet"><list-item><p><italic>F. nucleatum</italic> DNA</p></list-item><list-item><p>Prostaglandin transporter—reference gene</p></list-item></list></p></list-item></list></sec><sec id="s2-1-2"><title>Materials and reagents</title><p><table-wrap id="tblu1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th/><th/></tr><tr><th/><th>Reagent</th><th>Manufacturer</th><th>Catalog #</th><th>Comments</th></tr></thead><tbody><tr><td/><td>Frozen human colon tumor samples <break/>and matched normal samples</td><td><sup>#</sup>iSpecimen</td><td/><td>Data include age, gender, ethnicity, <break/>diagnosis, histopathology report</td></tr><tr><td/><td>Gentra Puregene Genomic <break/>DNA extraction kit</td><td>Qiagen</td><td>158667</td><td>Replaces Qiagen 69504</td></tr><tr><td/><td>PicoGreen Assay</td><td><sup>#</sup>Life Technologies</td><td>P7589</td><td/></tr><tr><td/><td>Spectrophotometer</td><td><sup>#</sup>NanoDrop</td><td>ND1000</td><td/></tr><tr><td/><td>384-well optical PCR plate</td><td><sup>#</sup>Phoenix Research</td><td>MPS-3898</td><td/></tr><tr><td/><td>Fusobacteria forward qPCR primer</td><td colspan="2" rowspan="3">Part of a custom-designed <break/>Taqman primer/probe set <break/>(Applied Biosystems)</td><td>CAACCATTACTTTAACTCTA <break/>CCATGTTCA</td></tr><tr><td/><td>Fusobacteria reverse qPCR primer</td><td>GTTGACTTTACAGAAGGAGA <break/>TTATGTAAAAATC</td></tr><tr><td/><td>Fusobacteria FAM probe</td><td>TCAGCAACTTGTCCTTCTTGA <break/>TCTTTAAATGAACC<sup>†</sup></td></tr><tr><td/><td>PGT forward qPCR primer</td><td colspan="2" rowspan="3">Part of a custom-designed <break/>Taqman primer/probe set <break/>(Applied Biosystems) <break/> <break/><break/></td><td>ATCCCCAAAGCACCTGGTTT</td></tr><tr><td/><td>PGT reverse qPCR primer</td><td>AGAGGCCAAGATAGTCCTG <break/>GTAA</td></tr><tr><td/><td>PGT FAM probe</td><td>CCATCCATGTCCTCATCTC</td></tr><tr><td/><td>TaqMan Universal Master Mix</td><td>ABI</td><td><sup>#</sup>4304437</td><td/></tr><tr><td/><td>qPCR thermal cycling system</td><td>ABI</td><td><sup>#</sup>4351405</td><td>7900HT system</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p><sup>†</sup>Note: Probe sequence from original manuscript incorrect. Correct sequence seen here from <xref ref-type="bibr" rid="bib12">Flanagan et al., 2014</xref>.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s2-1-3"><title>Procedure</title><list list-type="order"><list-item><p>Obtain ~40 sets from frozen human CRC tumors with matched normal control, and an additional control group of age/ethnicity-matched tissue from healthy individuals.<list list-type="alpha-lower"><list-item><p>Tissue will have been flash-frozen in liquid nitrogen very soon after harvest.</p></list-item><list-item><p>Pathological data showing positive diagnosis for CRC will be included with samples.</p></list-item></list></p></list-item><list-item><p>Extract gDNA using Gentra Puregene genomic DNA extraction kit according to manufacturer’s instructions.</p></list-item><list-item><p>Quantify gDNA concentration by Nanodrop spectrophotometer.</p></list-item><list-item><p>Assemble 20 μL qPCR reactions in a 384-well optical PCR plate. Each sample is assayed in triplicate for each primer/probe set. Each reaction contains:<list list-type="alpha-lower"><list-item><p>5 ng of gDNA</p></list-item><list-item><p>18 μM of each primer</p></list-item><list-item><p>5 μM of probe</p></list-item><list-item><p>1 X final concentration of TaqMan Universal Master Mix</p></list-item></list></p></list-item><list-item><p>Perform amplification and detection of DNA using the following reaction conditions:<list list-type="alpha-lower"><list-item><p>2 min at 50°C</p></list-item><list-item><p>10 min at 95°C</p></list-item><list-item><p>40 cycles of 15 s at 95°C and 1 min at 60°C.</p></list-item></list></p></list-item><list-item><p>Calculate cycle threshold using the automated settings. Analyze and compute ΔΔ<italic>C</italic><sub>T</sub> values by normalizing to prostaglandin transporter reference gene.<list list-type="alpha-lower"><list-item><p>The mean ΔΔ<italic>C</italic><sub>T</sub> values from the technical replicates from the tumor and normal sample will be used to calculate the ratio of tumor versus normal for each matched biopsy.</p></list-item></list></p></list-item><list-item><p>Repeat steps 3–5 for each sample a second time.<list list-type="alpha-lower"><list-item><p>The mean ratios of ΔΔ<italic>C</italic><sub>T</sub> values in tumor versus normal sample from the two independent experimental replicates will be calculated for each matched biopsy.</p></list-item></list></p></list-item></list></sec><sec id="s2-1-4"><title>Deliverables</title><list list-type="bullet"><list-item><p>Data to be collected:<list list-type="bullet"><list-item><p>Descriptive data of gDNA samples including: patient sample age/sex, ethnicity, and % area of the tumor involved with necrosis.</p></list-item><list-item><p>Purity (<italic>A</italic><sub>260/280</sub> and <italic>A</italic><sub>260/230</sub> ratios) and concentration of isolated total gDNA from tumor biopsies.</p></list-item><list-item><p>Raw qRT-PCR values, as well as analyzed ΔΔ<italic>C</italic><sub>T</sub> values for each tumor and matched biopsy sample. Bar graph of mean relative abundance of <italic>F. nucleatum</italic> in tumor versus normal colorectal samples (compare to Figure 2A).</p></list-item></list></p></list-item></list></sec><sec id="s2-1-5"><title>Confirmatory analysis plan</title><p>This replication attempt will perform the statistical analysis listed below:</p><list list-type="bullet"><list-item><p>Statistical analysis of replication data:<list list-type="bullet"><list-item><p>Note: At the time of analysis, we will perform the Shapiro–Wilk test and generate a quantile–quantile (<italic>q</italic>–<italic>q</italic>) plot to assess the normality of the data. If the data appear skewed, we will perform the appropriate transformation in order to proceed with the proposed statistical analysis. If this is not possible, we will perform the equivalent nonparametric test (e.g., Wilcoxon-signed rank test).</p></list-item><list-item><p>One-sample Student’s <italic>t</italic>-test using the log of the mean ratios of ΔΔ<italic>C</italic><sub>T</sub> values from the two independent experimental replicates, tumor ΔΔ<italic>C</italic><sub>T</sub>/matched within individual controls compared to a mean value of zero.</p></list-item></list></p></list-item><list-item><p>Additional exploratory analysis:<list list-type="bullet"><list-item><p>Two Student’s <italic>t</italic>-tests with Bonferroni correction comparing absolute values from:<list list-type="bullet"><list-item><p>Mean tumor <italic>Fusobacterium</italic> abundance versus within subject matched control (paired)</p></list-item><list-item><p>Mean tumor <italic>Fusobacterium</italic> abundance versus healthy matched control (unpaired)</p></list-item></list></p></list-item></list></p></list-item><list-item><p>Meta-analysis of original and replication attempt effect sizes:<list list-type="bullet"><list-item><p>Compute the effect size, compare it against the effect size in the original paper and use a random effects meta-analytic approach to combine the original and replication effects, which will be presented as a forest plot.</p></list-item></list></p></list-item></list></sec><sec id="s2-1-6"><title>Known differences from the original study</title><p>All known differences are listed in the 'Materials and reagents' section with the originally used item listed in the comments section. All differences have the same capabilities as the original and are not expected to alter the experimental design. We have added an additional control of matched gDNA from healthy individuals.</p></sec><sec id="s2-1-7"><title>Provisions for quality control</title><p>The sample purity (<italic>A</italic><sub>260/280</sub> and <italic>A</italic><sub>260/230</sub> ratios) of the isolated gDNA from each sample will be reported. All of the raw data, including the analysis files, will be uploaded to the project page on the OSF (<ext-link ext-link-type="uri" xlink:href="https://osf.io/v4se2">https://osf.io/v4se2</ext-link>) and made publically available.</p></sec></sec><sec id="s2-2"><title>Power calculations</title><p>For a detailed breakdown of all power calculations, see spreadsheet at <ext-link ext-link-type="uri" xlink:href="https://osf.io/yadgq/?view_only=748a4e8faa854109a9082ddebd72d8b6">https://osf.io/yadgq/</ext-link></p></sec><sec id="s2-3"><title>Protocol 1</title><sec id="s2-3-1"><title>Summary of original data</title><list list-type="bullet"><list-item> <p>Note: Data estimated from graph reported in Figure 2.</p></list-item></list><p><table-wrap id="tblu2" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/></tr><tr><th>Sample</th><th>Log (mean)</th><th><italic>N</italic></th></tr></thead><tbody><tr><td>1</td><td>‑1.5787</td><td>2</td></tr><tr><td>2</td><td>‑1.1957</td><td>2</td></tr><tr><td>3</td><td>‑0.9277</td><td>2</td></tr><tr><td>4</td><td>‑0.8766</td><td>2</td></tr><tr><td>5</td><td>‑0.5192</td><td>2</td></tr><tr><td>6</td><td>‑0.4468</td><td>2</td></tr><tr><td>7</td><td>‑0.4128</td><td>2</td></tr><tr><td>8</td><td>‑0.3149</td><td>2</td></tr><tr><td>9</td><td>‑0.2936</td><td>2</td></tr><tr><td>10</td><td>‑0.2681</td><td>2</td></tr><tr><td>11</td><td>‑0.2766</td><td>2</td></tr><tr><td>12</td><td>‑0.2383</td><td>2</td></tr><tr><td>13</td><td>‑0.234</td><td>2</td></tr><tr><td>14</td><td>‑0.2</td><td>2</td></tr><tr><td>15</td><td>‑0.1787</td><td>2</td></tr><tr><td>16</td><td>‑0.1703</td><td>2</td></tr><tr><td>17</td><td>‑0.1617</td><td>2</td></tr><tr><td>18</td><td>‑0.1362</td><td>2</td></tr><tr><td>19</td><td>‑0.0681</td><td>2</td></tr><tr><td>20</td><td>‑0.0298</td><td>2</td></tr><tr><td>21</td><td>0.034</td><td>2</td></tr><tr><td>22</td><td>0.0128</td><td>2</td></tr><tr><td>23</td><td>0.0095</td><td>2</td></tr><tr><td>24</td><td>0.017</td><td>2</td></tr><tr><td>25</td><td>0.0213</td><td>2</td></tr><tr><td>26</td><td>0.0213</td><td>2</td></tr><tr><td>27</td><td>0.0255</td><td>2</td></tr><tr><td>28</td><td>0.0128</td><td>2</td></tr><tr><td>29</td><td>0.017</td><td>2</td></tr><tr><td>30</td><td>0.0128</td><td>2</td></tr><tr><td>31</td><td>0.017</td><td>2</td></tr><tr><td>32</td><td>0.0255</td><td>2</td></tr><tr><td>33</td><td>0.0213</td><td>2</td></tr><tr><td>34</td><td>0.0301</td><td>2</td></tr><tr><td>35</td><td>0.034</td><td>2</td></tr><tr><td>36</td><td>0.0555</td><td>2</td></tr><tr><td>37</td><td>0.1362</td><td>2</td></tr><tr><td>38</td><td>0.1447</td><td>2</td></tr><tr><td>39</td><td>0.1745</td><td>2</td></tr><tr><td>40</td><td>0.1915</td><td>2</td></tr><tr><td>41</td><td>0.2</td><td>2</td></tr><tr><td>42</td><td>0.2086</td><td>2</td></tr><tr><td>43</td><td>0.217</td><td>2</td></tr><tr><td>44</td><td>0.2213</td><td>2</td></tr><tr><td>45</td><td>0.2596</td><td>2</td></tr><tr><td>46</td><td>0.4043</td><td>2</td></tr><tr><td>47</td><td>0.4468</td><td>2</td></tr><tr><td>48</td><td>0.4511</td><td>2</td></tr><tr><td>49</td><td>0.4681</td><td>2</td></tr><tr><td>50</td><td>0.4979</td><td>2</td></tr><tr><td>51</td><td>0.5064</td><td>2</td></tr><tr><td>52</td><td>0.5021</td><td>2</td></tr><tr><td>53</td><td>0.549</td><td>2</td></tr><tr><td>54</td><td>0.5787</td><td>2</td></tr><tr><td>55</td><td>0.5787</td><td>2</td></tr><tr><td>56</td><td>0.5872</td><td>2</td></tr><tr><td>57</td><td>0.6085</td><td>2</td></tr><tr><td>58</td><td>0.6213</td><td>2</td></tr><tr><td>59</td><td>0.6553</td><td>2</td></tr><tr><td>60</td><td>0.6979</td><td>2</td></tr><tr><td>61</td><td>0.7234</td><td>2</td></tr><tr><td>62</td><td>0.7617</td><td>2</td></tr><tr><td>63</td><td>0.8043</td><td>2</td></tr><tr><td>64</td><td>0.8298</td><td>2</td></tr><tr><td>65</td><td>0.966</td><td>2</td></tr><tr><td>66</td><td>0.9617</td><td>2</td></tr><tr><td>67</td><td>1.0042</td><td>2</td></tr><tr><td>68</td><td>1.0128</td><td>2</td></tr><tr><td>69</td><td>1.017</td><td>2</td></tr><tr><td>70</td><td>1.0255</td><td>2</td></tr><tr><td>71</td><td>1.0681</td><td>2</td></tr><tr><td>72</td><td>1.0596</td><td>2</td></tr><tr><td>73</td><td>1.0851</td><td>2</td></tr><tr><td>74</td><td>1.1234</td><td>2</td></tr><tr><td>75</td><td>1.1958</td><td>2</td></tr><tr><td>76</td><td>1.3149</td><td>2</td></tr><tr><td>77</td><td>1.3149</td><td>2</td></tr><tr><td>78</td><td>1.4085</td><td>2</td></tr><tr><td>79</td><td>1.6298</td><td>2</td></tr><tr><td>80</td><td>1.7575</td><td>2</td></tr><tr><td>81</td><td>1.783</td><td>2</td></tr><tr><td>82</td><td>1.8723</td><td>2</td></tr><tr><td>83</td><td>1.9404</td><td>2</td></tr><tr><td>84</td><td>1.983</td><td>2</td></tr><tr><td>85</td><td>2</td><td>2</td></tr><tr><td>86</td><td>2.2553</td><td>2</td></tr><tr><td>87</td><td>2.4298</td><td>2</td></tr><tr><td>88</td><td>2.4723</td><td>2</td></tr><tr><td>89</td><td>2.4723</td><td>2</td></tr><tr><td>90</td><td>2.5532</td><td>2</td></tr><tr><td>91</td><td>2.6723</td><td>2</td></tr><tr><td>92</td><td>2.6893</td><td>2</td></tr><tr><td>93</td><td>2.9064</td><td>2</td></tr><tr><td>94</td><td>3.0596</td><td>2</td></tr><tr><td>95</td><td>3.2425</td><td>2</td></tr><tr><td>96</td><td>3.3447</td><td>2</td></tr><tr><td>97</td><td>3.5872</td><td>2</td></tr><tr><td>98</td><td>3.8</td><td>2</td></tr><tr><td>99</td><td>4.261</td><td>2</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="s2-4"><title>Test family</title><list list-type="bullet"><list-item><p>Ratio one-sample <italic>t</italic>-test: a<sub>error</sub> = 0.05, µ = 0.</p></list-item></list></sec><sec id="s2-5"><title>Power calculations</title><list list-type="bullet"><list-item><p>Ratio <italic>t</italic>-test and power calculations were performed with R software, version 3.1.2 (<xref ref-type="bibr" rid="bib28">Team RC 2014</xref>).</p></list-item></list><p><table-wrap id="tblu3" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th/><th/><th/></tr><tr><th/><th/><th>Mean</th><th>Effect <break/>size <italic>d</italic></th><th>A priori power</th><th>Total sample size</th></tr></thead><tbody><tr><td/><td>Ratio</td><td>0.75893838</td><td>0.5024568</td><td>87.26%</td><td>40*</td></tr></tbody></table><table-wrap-foot><fn id="tblfn2"><p>*Forty total ratios (40 tumor 40 matched controls) will be used.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s2-6"><title>Additional exploratory analysis</title><sec id="s2-6-1"><title>Test family</title><list list-type="bullet"><list-item><p>Paired Student’s <italic>t</italic>-test (two-tailed): a<sub>error</sub> = 0.025.</p></list-item></list></sec><sec id="s2-6-2"><title>Power calculations</title><list list-type="bullet"><list-item><p>Sensitivity calculations were performed with G*Power software, version 3.1.7 (<xref ref-type="bibr" rid="bib10">Faul et al., 2007</xref>).</p></list-item></list><p><table-wrap id="tblu4" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th/><th/><th/></tr><tr><th/><th>Group 1</th><th>Group 2</th><th>Detectable effect <break/>size <italic>d</italic></th><th>A priori power</th><th>Total <break/>sample <break/>size</th></tr></thead><tbody><tr><td/><td>Tumor sample</td><td>Adjacent matched <break/>control</td><td>0.50384</td><td>80%</td><td>40</td></tr></tbody></table></table-wrap></p></sec><sec id="s2-6-3"><title>Test family</title><list list-type="bullet"><list-item><p>Independent Student’s <italic>t</italic>-test (two-tailed): a<sub>error</sub> = 0.025.</p></list-item></list></sec><sec id="s2-6-4"><title>Power calculations</title><list list-type="bullet"><list-item><p>Sensitivity calculations were performed with G*Power software, version 3.1.7. (<xref ref-type="bibr" rid="bib10">Faul et al., 2007</xref>).</p></list-item></list><p><table-wrap id="tblu5" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th/><th/><th/></tr><tr><th/><th>Group 1</th><th>Group 2</th><th>Detectable effect <break/>size <italic>d</italic></th><th>A priori power</th><th>Total <break/>sample <break/>size</th></tr></thead><tbody><tr><td/><td>Tumor sample</td><td>Healthy <break/>individual matched <break/>control</td><td>0.7007</td><td>80%</td><td>40</td></tr></tbody></table></table-wrap></p></sec></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The Reproducibility Project: Cancer Biology core team thank Courtney Soderberg at the Center for Open Science for assistance with statistical analyses. We also thank the following companies for generously donating reagents to the Reproducibility Project: Cancer Biology; American Type Culture Collection (ATCC), Applied Biological Materials, BioLegend, Charles River Laboratories, Corning, DDC Medical, EMD Millipore, Harlan Laboratories, LI-COR Biosciences, Mirus Bio, Novus Biologicals, Sigma–Aldrich, and System Biosciences (SBI).</p></ack><sec id="s3" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>JR: ARQ Genetics is a Science Exchange-associated lab.</p></fn><fn fn-type="conflict" id="conf2"><p>The other authors declare that no competing interests exist.</p></fn><fn fn-type="conflict" id="conf3"><p>RP:CB: EI, FT, JL, NP: Employed by and hold shares in Science Exchange Inc.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>JR, Drafting or revising the article</p></fn><fn fn-type="con" id="con2"><p>NM, Drafting or revising the article</p></fn><fn fn-type="con" id="con3"><p>KO, Drafting or revising the article</p></fn><fn fn-type="con" id="con4"><p>RP:CB, Conception and design; Drafting or revising the article</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrieta</surname><given-names>M-C</given-names></name><name><surname>Stiemsma</surname><given-names>LT</given-names></name><name><surname>Amenyogbe</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>EM</given-names></name><name><surname>Finlay</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The intestinal microbiome in early life: health and disease</article-title><source>Frontiers in Immunology</source><volume>5</volume><fpage>427</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2014.00427</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajzer</surname><given-names>M</given-names></name><name><surname>Seeley</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Physiology: obesity and gut flora</article-title><source>Nature</source><volume>444</volume><fpage>1009</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1038/4441009a</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>K</given-names></name><name><surname>DeCoffe</surname><given-names>D</given-names></name><name><surname>Molcan</surname><given-names>E</given-names></name><name><surname>Gibson</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease</article-title><source>Nutrients</source><volume>4</volume><fpage>1095</fpage><lpage>1119</lpage><pub-id pub-id-type="doi">10.3390/nu4081095</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäckhed</surname><given-names>F</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Sonnenburg</surname><given-names>JL</given-names></name><name><surname>Peterson</surname><given-names>DA</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Host-bacterial mutualism in the human intestine</article-title><source>Science</source><volume>307</volume><fpage>1915</fpage><lpage>1920</lpage><pub-id pub-id-type="doi">10.1126/science.1104816</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellarin</surname><given-names>M</given-names></name><name><surname>Warren</surname><given-names>RL</given-names></name><name><surname>Freeman</surname><given-names>JD</given-names></name><name><surname>Dreolini</surname><given-names>L</given-names></name><name><surname>Krzywinski</surname><given-names>M</given-names></name><name><surname>Strauss</surname><given-names>J</given-names></name><name><surname>Barnes</surname><given-names>R</given-names></name><name><surname>Watson</surname><given-names>P</given-names></name><name><surname>Allen-Vercoe</surname><given-names>E</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma</article-title><source>Genome Research</source><volume>22</volume><fpage>299</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1101/gr.126516.111</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H-M</given-names></name><name><surname>Yu</surname><given-names>Y-N</given-names></name><name><surname>Wang</surname><given-names>J-L</given-names></name><name><surname>Lin</surname><given-names>Y-W</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>C-Q</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Z-J</given-names></name><name><surname>Yuan</surname><given-names>Y-Z</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>J-X</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Fang</surname><given-names>D-C</given-names></name><name><surname>Zou</surname><given-names>W</given-names></name><name><surname>Fang</surname><given-names>J-Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma</article-title><source>American Journal of Clinical Nutrition</source><volume>97</volume><fpage>1044</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.3945/ajcn.112.046607</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A role for the gut microbiota in IBS</article-title><source>Nature Reviews Gastroenterology &amp; Hepatology</source><volume>11</volume><fpage>497</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2014.40</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dulal</surname><given-names>S</given-names></name><name><surname>Keku</surname><given-names>TO</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gut microbiome and colorectal adenomas</article-title><source>The Cancer Journal</source><volume>20</volume><fpage>225</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1097/PPO.0000000000000050</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Errington</surname><given-names>TM</given-names></name><name><surname>Iorns</surname><given-names>E</given-names></name><name><surname>Gunn</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>FE</given-names></name><name><surname>Lomax</surname><given-names>J</given-names></name><name><surname>Nosek</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An open investigation of the reproducibility of cancer biology research</article-title><source>eLife</source><volume>3</volume><elocation-id>e04333</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.04333</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Lang</surname><given-names>A-G</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title><source>Behavior Research Methods</source><volume>39</volume><fpage>175</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.3758/BF03193146</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearon</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular genetics of colorectal cancer</article-title><source>Annual Review of Pathology: Mechanisms of Disease</source><volume>6</volume><fpage>479</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-011110-130235</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flanagan</surname><given-names>L</given-names></name><name><surname>Schmid</surname><given-names>J</given-names></name><name><surname>Ebert</surname><given-names>M</given-names></name><name><surname>Soucek</surname><given-names>P</given-names></name><name><surname>Kunicka</surname><given-names>T</given-names></name><name><surname>Liska</surname><given-names>V</given-names></name><name><surname>Bruha</surname><given-names>J</given-names></name><name><surname>Neary</surname><given-names>P</given-names></name><name><surname>Dezeeuw</surname><given-names>N</given-names></name><name><surname>Tommasino</surname><given-names>M</given-names></name><name><surname>Jenab</surname><given-names>M</given-names></name><name><surname>Prehn</surname><given-names>JH</given-names></name><name><surname>Hughes</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome</article-title><source>European Journal of Clinical Microbiology &amp; Infectious Diseases</source><volume>33</volume><fpage>1381</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1007/s10096-014-2081-3</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gur</surname><given-names>C</given-names></name><name><surname>Ibrahim</surname><given-names>Y</given-names></name><name><surname>Isaacson</surname><given-names>B</given-names></name><name><surname>Yamin</surname><given-names>R</given-names></name><name><surname>Abed</surname><given-names>J</given-names></name><name><surname>Gamliel</surname><given-names>M</given-names></name><name><surname>Enk</surname><given-names>J</given-names></name><name><surname>Bar-On</surname><given-names>Y</given-names></name><name><surname>Stanietsky-Kaynan</surname><given-names>N</given-names></name><name><surname>Coppenhagen-Glazer</surname><given-names>S</given-names></name><name><surname>Shussman</surname><given-names>N</given-names></name><name><surname>Almogy</surname><given-names>G</given-names></name><name><surname>Cuapio</surname><given-names>A</given-names></name><name><surname>Hofer</surname><given-names>E</given-names></name><name><surname>Mevorach</surname><given-names>D</given-names></name><name><surname>Tabib</surname><given-names>A</given-names></name><name><surname>Ortenberg</surname><given-names>R</given-names></name><name><surname>Markel</surname><given-names>G</given-names></name><name><surname>Miklić</surname><given-names>K</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Brennan</surname><given-names>CA</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name><name><surname>Bachrach</surname><given-names>G</given-names></name><name><surname>Mandelboim</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Binding of the Fap2 protein of fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack</article-title><source>Immunity</source><volume>42</volume><fpage>344</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.01.010</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hold</surname><given-names>GL</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Grange</surname><given-names>C</given-names></name><name><surname>Watt</surname><given-names>ER</given-names></name><name><surname>El-Omar</surname><given-names>EM</given-names></name><name><surname>Mukhopadhya</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?</article-title><source>World Journal of Gastroenterology</source><volume>20</volume><fpage>1192</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i5.1192</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>ML</given-names></name><name><surname>Tomaro-Duchesneau</surname><given-names>C</given-names></name><name><surname>Prakash</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The gut microbiome, probiotics, bile acids axis, and human health</article-title><source>Trends in Microbiology</source><volume>22</volume><fpage>306</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2014.04.010</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keku</surname><given-names>TO</given-names></name><name><surname>Dulal</surname><given-names>S</given-names></name><name><surname>Deveaux</surname><given-names>A</given-names></name><name><surname>Jovov</surname><given-names>B</given-names></name><name><surname>Han</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The gastrointestinal microbiota and colorectal cancer</article-title><source>American Journal of Physiology - Gastrointestinal and Liver Physiology</source><volume>308</volume><fpage>G351</fpage><lpage>G363</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00360.2012</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostic</surname><given-names>AD</given-names></name><name><surname>Chun</surname><given-names>E</given-names></name><name><surname>Robertson</surname><given-names>L</given-names></name><name><surname>Glickman</surname><given-names>JN</given-names></name><name><surname>Gallini</surname><given-names>CA</given-names></name><name><surname>Michaud</surname><given-names>M</given-names></name><name><surname>Clancy</surname><given-names>TE</given-names></name><name><surname>Chung</surname><given-names>DC</given-names></name><name><surname>Lochhead</surname><given-names>P</given-names></name><name><surname>Hold</surname><given-names>GL</given-names></name><name><surname>El-Omar</surname><given-names>EM</given-names></name><name><surname>Brenner</surname><given-names>D</given-names></name><name><surname>Fuchs</surname><given-names>CS</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment</article-title><source>Cell Host &amp; Microbe</source><volume>14</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.07.007</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostic</surname><given-names>AD</given-names></name><name><surname>Gevers</surname><given-names>D</given-names></name><name><surname>Pedamallu</surname><given-names>CS</given-names></name><name><surname>Michaud</surname><given-names>M</given-names></name><name><surname>Duke</surname><given-names>F</given-names></name><name><surname>Earl</surname><given-names>AM</given-names></name><name><surname>Ojesina</surname><given-names>AI</given-names></name><name><surname>Jung</surname><given-names>J</given-names></name><name><surname>Bass</surname><given-names>AJ</given-names></name><name><surname>Tabernero</surname><given-names>J</given-names></name><name><surname>Baselga</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Shivdasani</surname><given-names>RA</given-names></name><name><surname>Ogino</surname><given-names>S</given-names></name><name><surname>Birren</surname><given-names>BW</given-names></name><name><surname>Huttenhower</surname><given-names>C</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genomic analysis identifies association of fusobacterium with colorectal carcinoma</article-title><source>Genome Research</source><volume>22</volume><fpage>292</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1101/gr.126573.111</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>[Fecal intestinal flora in patients with colon adenoma and colon cancer]</article-title><source>Nihon Shokakibyo Gakkai Zasshi</source><volume>87</volume><fpage>771</fpage><lpage>779</lpage></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Peterson</surname><given-names>DA</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ecological and evolutionary forces shaping microbial diversity in the human intestine</article-title><source>Cell</source><volume>124</volume><fpage>837</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.02.017</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AN</given-names></name><name><surname>Araújo-Pérez</surname><given-names>F</given-names></name><name><surname>Azcárate-Peril</surname><given-names>A</given-names></name><name><surname>Yeh</surname><given-names>JJ</given-names></name><name><surname>Sandler</surname><given-names>RS</given-names></name><name><surname>Keku</surname><given-names>TO</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fusobacterium is associated with colorectal adenomas</article-title><source>PLoS ONE</source><volume>8</volume><elocation-id>e53653</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053653</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mira-Pascual</surname><given-names>L</given-names></name><name><surname>Cabrera-Rubio</surname><given-names>R</given-names></name><name><surname>Ocon</surname><given-names>S</given-names></name><name><surname>Costales</surname><given-names>P</given-names></name><name><surname>Parra</surname><given-names>A</given-names></name><name><surname>Suarez</surname><given-names>A</given-names></name><name><surname>Moris</surname><given-names>F</given-names></name><name><surname>Rodrigo</surname><given-names>L</given-names></name><name><surname>Mira</surname><given-names>A</given-names></name><name><surname>Collado</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers</article-title><source>Journal of Gastroenterology</source><volume>50</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1007/s00535-014-0963-x</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundade</surname><given-names>R</given-names></name><name><surname>Imperiale</surname><given-names>TF</given-names></name><name><surname>Prabhu</surname><given-names>L</given-names></name><name><surname>Loehrer</surname><given-names>PJ</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genetic pathways, prevention, and treatment of sporadic colorectal cancer</article-title><source>Oncoscience</source><volume>1</volume><fpage>400</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.18632/oncoscience.59</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nugent</surname><given-names>JL</given-names></name><name><surname>McCoy</surname><given-names>AN</given-names></name><name><surname>Addamo</surname><given-names>CJ</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Sandler</surname><given-names>RS</given-names></name><name><surname>Keku</surname><given-names>TO</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas</article-title><source>Journal of Proteome Research</source><volume>13</volume><fpage>1921</fpage><lpage>1929</lpage><pub-id pub-id-type="doi">10.1021/pr4009783</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez</surname><given-names>JM</given-names></name><name><surname>Murphy</surname><given-names>K</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Kober</surname><given-names>OI</given-names></name><name><surname>Juge</surname><given-names>N</given-names></name><name><surname>Avershina</surname><given-names>E</given-names></name><name><surname>Rudi</surname><given-names>K</given-names></name><name><surname>Narbad</surname><given-names>A</given-names></name><name><surname>Jenmalm</surname><given-names>MC</given-names></name><name><surname>Marchesi</surname><given-names>JR</given-names></name><name><surname>Collado</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The composition of the gut microbiota throughout life, with an emphasis on early life</article-title><source>Microbial Ecology in Health &amp; Disease</source><volume>26</volume><fpage>26050</fpage><pub-id pub-id-type="doi">10.3402/mehd.v26.26050</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubinstein</surname><given-names>MR</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Han</surname><given-names>YW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating e-cadherin/-catenin signaling via its FadA adhesinn</article-title><source>Cell Host &amp; Microbe</source><volume>14</volume><fpage>195</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.07.012</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahara</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>E</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Maruyama</surname><given-names>R</given-names></name><name><surname>Chung</surname><given-names>W</given-names></name><name><surname>Garriga</surname><given-names>J</given-names></name><name><surname>Jelinek</surname><given-names>J</given-names></name><name><surname>Yamano</surname><given-names>H.-o.</given-names></name><name><surname>Sugai</surname><given-names>T</given-names></name><name><surname>An</surname><given-names>B</given-names></name><name><surname>Shureiqi</surname><given-names>I</given-names></name><name><surname>Toyota</surname><given-names>M</given-names></name><name><surname>Kondo</surname><given-names>Y</given-names></name><name><surname>Estecio</surname><given-names>MRH</given-names></name><name><surname>Issa</surname><given-names>J-PJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fusobacterium in colonic flora and molecular features of colorectal carcinoma</article-title><source>Cancer Research</source><volume>74</volume><fpage>1311</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1865</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Team</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2014">2014</year><source>R: a language and environment for statistical computing</source><publisher-name>R Foundation for Statistical Computing</publisher-name><publisher-loc>Vienna, Austria</publisher-loc></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Fearon</surname><given-names>ER</given-names></name><name><surname>Hamilton</surname><given-names>SR</given-names></name><name><surname>Kern</surname><given-names>SE</given-names></name><name><surname>Preisinger</surname><given-names>AC</given-names></name><name><surname>Leppert</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>R</given-names></name><name><surname>Smits</surname><given-names>AM</given-names></name><name><surname>Bos</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Genetic alterations during colorectal-tumor development</article-title><source>New England Journal of Medicine</source><volume>319</volume><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1056/NEJM198809013190901</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>RL</given-names></name><name><surname>Freeman</surname><given-names>DJ</given-names></name><name><surname>Pleasance</surname><given-names>S</given-names></name><name><surname>Watson</surname><given-names>P</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Cochrane</surname><given-names>K</given-names></name><name><surname>Allen-Vercoe</surname><given-names>E</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Co-occurrence of anaerobic bacteria in colorectal carcinomas</article-title><source>Microbiome</source><volume>1</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/2049-2618-1-16</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.10012.002</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Sears</surname><given-names>Cynthia L</given-names></name><role>Reviewing editor</role><aff id="aff5"><institution>Johns Hopkins University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your work entitled &quot;Registered report: <italic>Fusobacterium nucleatum</italic> infection is prevalent in human colorectal carcinoma&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by four peer reviewers, and the evaluation has been overseen by a guest Reviewing Editor and Sean Morrison as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The project goal is to test the reproducibility of the results in the Castellarin et al., 2012 paper in which <italic>Fusobacterium</italic> was associated with CRC by qPCR detection of <italic>Fusobacterium</italic> (versus a reference gene) in DNA isolated from colon tumors compared to matched uninvolved tissue and normal tissue from age-matched controls.</p><p>Essential revisions:</p><p>After discussion among all reviewers, the key clarifications requested are to define in more detail the source of the populations to be studied. Information about how subjects and controls will be recruited, how disease will be defined (including histopathology), how samples will be obtained as well as length and type of storage of samples should be explicitly stated. How many healthy individuals will be included in the study? Are tissues from healthy controls obtained through biopsy or colorectal resection? The title page should be corrected to reflect that the project is human subjects research.</p><p>[Editors’ note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The previous decision letter after peer review is shown below.]</p><p>Thank you for submitting your work entitled &quot;Registered report: <italic>Fusobacterium nucleatum</italic> infection is prevalent in human colorectal carcinoma&quot; for consideration at <italic>eLife</italic>. Your Registered Report has been evaluated by Sean Morrison (Senior editor) and a guest Reviewing Editor with appropriate expertise, and the decision was reached after discussions between the two of us. We regret to inform you that this version of the Registered Report will not be considered further for publication in <italic>eLife</italic>.</p><p>Unfortunately the proposed replication misses at least one key issue in this area of work. There are several reports of finding excess <italic>Fusobacterium</italic> in a subset of colon cancers versus matched normal and we have two major concerns:</p><p>1) Normal tissues from cancer hosts are not normal controls for these experiments (the authors would need to identify a bank of appropriate colonoscopy control biopsies or age-match normal tissues from rapid autopsies).</p><p>2) The key result that needs to be replicated is whether <italic>Fusobacterium nucleatum</italic> versus other species induce tumorigenesis in tumor-susceptible murine models. Addressing this key aspect of <italic>Fusobacterium</italic> biology by the Reproducibility Project is essential before we can move forwards with further in-depth review. Absent this experiment, it will not be possible to conclude whether they key claims in the paper in question are reproducible.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.10012.003</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>Essential revisions:</italic></p><p><italic>After discussion among all reviewers, the key clarifications requested are to define in more detail the source of the populations to be studied. Information about how subjects and controls will be recruited, how disease will be defined (including histopathology), how samples will be obtained as well as length and type of storage of samples should be explicitly stated. How many healthy individuals will be included in the study? Are tissues from healthy controls obtained through biopsy or colorectal resection? The title page should be corrected to reflect that the project is human subjects’ research.</italic></p><p>We have added clarifications to the manuscript to address these questions, but have answered more specifically below:</p><p>1) We will obtain tumor tissue samples from, iSpecimen located in Boston, MA. They have provided us with the information you requested.</p><p>2) The source population is defined as in the original manuscript: 50 years of age ( /- 5-10 years), normal control donors are matched for age, gender, and ethnicity and are collected from patients during surgery (either partial colectomy, ileocolectomy, colorectal resection or proctocolectomy). Samples are frozen in liquid nitrogen within 30 minutes of extraction.</p><p>3) iSpecimen represents multiple medical centers which use in-house pathologists to conduct histology on sections of all samples to confirm diagnosis.</p><p>4) The kit for gDNA extraction is a similar kit from Qiagen and will quantify gDNA using a NanoDrop.</p><p>Since the Registered Report does not involve using human tissue, but rather the proposed plan to use it, we typically do not list the Registered Report as a Human Subject study. However, we will include human subjects research information with the Final Report of replication results.</p><p>[Editors’ note: the author responses to the previous round of peer review follow.]</p><p><italic>Unfortunately the proposed replication misses at least one key issue in this area of work. There are several reports of finding excess Fusobacterium in a subset of colon cancers versus matched normal and we have two major concerns:</italic></p><p><italic>1) Normal tissues from cancer hosts are not normal controls for these experiments (the authors would need to identify a bank of appropriate colonoscopy control biopsies or age-match normal tissues from rapid autopsies).</italic></p><p>Adding additional aspects not included in the original study can be of scientific interest, and can be included if it is possible to balance them with the main aim of this project: to perform a direct replication of the original experiment(s). As such, we agree with the editors that there is scientific interest in including these additional control samples. We have added this control to the manuscript and made appropriate adjustments to our power calculations.</p><p><italic>2) The key result that needs to be replicated is whether Fusobacterium nucleatum versus other species induce tumorigenesis in tumor-susceptible murine models. Addressing this key aspect of Fusobacterium biology by the Reproducibility Project is essential before we can move forwards with further in-depth review. Absent this experiment, it will not be possible to conclude whether they key claims in the paper in question are reproducible.</italic></p><p>We agree that investigating whether this <italic>Fusobacterium</italic> ssp. in particular is responsible for inducing tumorigenesis is a critical extension of the Castellarin study. However, this project focuses on direct replication of the experiments as detailed in the original report and with information provided by the original authors to understand the reproducibility of the reported results. Aspects of an experiment not included in the original study are occasionally added (such as negative controls, reagent verification, etc.) to ensure the quality of the research, but are only included if it is possible to balance them with the main aim of this project: to perform a direct replication of the original experiment(s). We feel that the addition of this experiment, despite it being an important question in the field, is outside of the scope of this project.</p></body></sub-article></article>